These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6075620)

  • 1. Studies on active immunization in measles, mumps and rubella.
    Stokes J
    Johns Hopkins Med J; 1967 Nov; 121(5):314-28. PubMed ID: 6075620
    [No Abstract]   [Full Text] [Related]  

  • 2. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps.
    Rose VL
    Am Fam Physician; 1998 Nov; 58(7):1682, 1685-6. PubMed ID: 9824963
    [No Abstract]   [Full Text] [Related]  

  • 3. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination against virus disease.
    Krugman S
    Maandschr Kindergeneeskd; 1968 Nov; 36(7):198-206. PubMed ID: 5715991
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mumps and rubella consensus conference.
    Can Commun Dis Rep; 1994 Oct; 20(19):165-76. PubMed ID: 7804152
    [No Abstract]   [Full Text] [Related]  

  • 8. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
    Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C
    Microbios; 1996; 88(356):143-8. PubMed ID: 9141711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topics in clinical medicine. New vaccines against viral diseases: mumps, rubella, and measles.
    Seto DS; Carver DH
    Johns Hopkins Med J; 1969 Apr; 124(4):231-7. PubMed ID: 5774148
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 12. Toward prophylaxis of prenatal infection by viruses.
    Hilleman MR
    Obstet Gynecol; 1969 Apr; 33(4):461-9. PubMed ID: 4887325
    [No Abstract]   [Full Text] [Related]  

  • 13. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A; Giorgi-Rossi P; Sangalli M; Spadea T; Perucci CA
    Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract]   [Full Text] [Related]  

  • 14. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles, mumps, and rubella: prevention.
    Booy R; Sengupta N; Bedford H; Elliman D
    Clin Evid; 2006 Jun; (15):448-68. PubMed ID: 16973018
    [No Abstract]   [Full Text] [Related]  

  • 16. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IAP guidelines on optional vaccines and related matters.
    John TJ
    Indian Pediatr; 1999 Jul; 36(7):677-9. PubMed ID: 10740304
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
    Heath TC; Burgess MA; Forrest JM
    Commun Dis Intell; 1998 Aug; 22(8):157-8. PubMed ID: 9735550
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.